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Summary Tissue samples from 59 patients with lung cancer have been used to establish cell lines in culture.
The primary diagnosis was small cell carcinoma in all except four. Most of the samples were of bone marrow
but pleural effusions, lymph node biopsies and skin metastases were also included. The samples were usually
split between HITES serum-free medium and HITES plus 2.5% foetal calf serum. A total of 19 cell lines were
established and characterised. One line is large cell anaplastic lung carcinoma, four are B-lymphoblastoid and
fourteen are small cell lung cancer. Considerable heterogeneity in gross morphology, neuroendocrine
differentiation (by electron microscopy) and content of the enzyme L-dopa decarboxylase was seen. The use
of HITES plus 2.5% foetal calf serum resulted in better establishment ofcultures than did serum-free HITES.
Considerable advances in our knowledge regarding
the biology of small cell lung cancer (SCLC) have
occurred over the last few years. Much of this
knowledge has resulted from studies on cell lines
established from patients with SCLC (Gazdar et al.,
1980; Pettengill et al., 1980; Carney et al., 1983a). It
is now clear that SCLC lines differ in many
respects from lines of non-small cell lung cancer
(NSCLC) including possession of neuroendocrine
properties (Baylin et al., 1980; Sorenson et al.,
1981; Gazdar et al., 1981; Moody et al., 1981;
Marangos et al., 1982), ability to grow in a defined
medium (HITES) (Carney et al., 1981), cell surface
protein characteristics (Baylin et al., 1982) high
levels of the BB isoenzyme of creatine kinase
(Gazdar et al., 1981) and the presence of a specific
chromosome abnormality (Whang-Peng et al.,
1982). Although most lines of SCLC are similar in
characteristics, there exists a sub-group (termed
'variant' lines) which differ in some respects from
'classic' lines (Carney et al., 1984). These variant
lines may show differences in morphology, content
of the enzyme L-dopa decarboxylase (Carney et al.,
1984), radiation-response characteristics (Carney et
al., 1983b) and have amplification of the c-myc
oncogene (Little et al., 1983). A further class of
variant lines ('biochemical variants') has more
recently been described (Carney et al., 1985; Gazdar
et al., 1985). Such lines show classic SCLC
morphology but also some of the biochemical
changes seen in 'morphological variants'.
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From the viewpoint of clinical therapy, SCLC is
a particularly interesting disease in that a high
initial response rate to chemotherapy and radio-
therapy is still associated with rapid recurrence of
disease in most patients and a 3-year survival of
not more than 10%. This pattern raises interesting
questions regarding the nature of the tumour cell
heterogeneity in SCLC and the characteristics of
the cells responsible for regrowth. Over the last 21
months, we have been involved in a programme to
establish cell lines from patients presenting with
SCLC and to characterise the lines in terms of
established criteria. In this paper we report on the
establishment and characterisation of 19 cell lines
from clinical specimens.
Materials and methods
Patients
The patients included in this study were all seen for
treatment between November 1982 and May 1984.
They were almost all pathologically confirmed
SCLC patients who had received no previous treat-
ment for their disease. A small number of patients
are included who were thought to have SCLC at
the time the tissue sample was obtained but were
subsequently diagnosed as NSCLC. Two SCLC
patients are included who had received previous
chemotherapy for their disease and were in relapse
at the time of sampling.
Tissue samples
Tissue samples obtained from 59 patients with lung
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cancer in the course of diagnostic and staging
procedures were used to establish tumour lines in
cell culture. The primary diagnosis was small cell
carcinoma of the bronchus in all except four. Most
of the tissue obtained was bone marrow but, where
possible, biopsies of other involved sites such as
lymph nodes or skin metastases were also taken. (A
number of series have established a bone-marrow
involvement rate of 20% in SCLC patients at
presentation (Anner & Drewinko, 1977; Ihde et al.,
1979)). The tissue samples obtained comprised 47
bone marrow aspirates, 43 bone marrow trephines,
6 lymph node biopsies, 4 skin nodule biopsies, 7
pleural effusions and 3 bronchoscopy specimens.
Complementary samples were sent for routine
histological reporting. Laboratory samples were
prepared as described subsequently for cell culture
and, where growth was obtained, were maintained
where possible as continuous cultures.
Bone marrow was obtained from the posterior iliac
crest by aspiration and trephine using a Jamshidi or
Islam biopsy needle. One per cent lignocaine was
used as local anaesthetic, supplemented with i.v.
diazepam as a sedative and amnesic agent. Sterile
samples were obtained for cell culture, the trephines
being collected into a dry tube, and the aspirates
into a tube containing 5,000 IU preservative-free
calcium heparin (Leo 'minihep') to prevent clotting.
In cases where heavy malignant cell infiltration was
present, clotting occurred despite the anticoagulant.
Bone marrow aspirates thus collected consisted of
1-3 ml liquid marrow and blood. Separation of
nucleated cells was carried out by layering 4ml of
marrow, diluted with Hanks Solution on to 4ml of
Ficoll in a centrifuge tube. After centrifugation at
1,000 rpm for 20min, the Ficoll and supernatant
layer were pipetted off and diluted to 15ml with
HITES culture medium. After further centri-
fugation at 200g for 10min, the pellet was
resuspended in HITES medium and a cell count was
carried out using a haemocytometer.
Bone marrow trephines consisted of a core of
medullary bone measuring 5-10mm in length and
3 mm in diameter. Bone marrow was extracted by
agitation for 45min in a spinner bottle containing
1 mgml-1 bacterial neutral protease (Sigma Type
IX) in HITES medium. The suspension was filtered
through a glass funnel containing packed sterile
cotton gauze and centrifuged at 200g for 5min.
The pellet was resuspended in HITES medium and
a count performed.
Lymph node biopsies were obtained under local
anaesthesia using a large Menghini liver biopsy
needle. The nodes most frequently biopsied were
clinically malignant supraclavicular fossa nodes.
This biopsy technique yielded satisfactory core
samples, which in most cases consisted almost
entirely of tumour cells. Such cores were dis-
aggregated into single cell suspension using
bacterial neutral protease as described above.
Skin metastases in this series of patients were rare.
They generally presented as hard, discrete, dermal
or dermal-subdermal lumps and proved to be
relatively difficult to disaggregate into a single cell
suspension using mechanical methods and digestion
with neutral protease.
Bronchoscopy specimens of the primary tumour
were obtained from three patients. The specimens
were very small and heavily contaminated with
bacteria and necrotic debris. The crush artefact
typical of biopsies of small cell carcinoma was
frequently present in these and other specimens on
histological examination.
Pleural effusions when present are readily obtained
and often in large quantities. In addition to tumour
cells, they contained a mixture of red blood cells,
mesothelial cells, macrophages and other inflamma-
tory cells. Proteinaceous effusions had a tendency
to clot, drawing the cell content out of suspension.
In such cases, protease digestion was successful in
obtaining a cell suspension. Cells from pleural
effusions proved to be easier to establish in culture
than cells from other sources.
Cell yields from bone marrow specimens were esti-
mated by counting phase contrast viable nucleated
cells in a haemocytometer prior to setting up flask
cultures. The nucleated cell yield from aspirate and
trephine specimens was very comparable and cell
counts from the entire marrow series were generally
between 106 and 107 cells per specimen obtained.
Most of these were haemopoietic cells. The extent
of malignant cell infiltration was assessed from
reports on complementary specimens examined by
the haematology/pathology services. Cell yields
from node biopsies were similar to those obtained
from marrow samples, but node specimens
consisted of an almost pure population of
malignant cells, unlike those from marrow. Yields
from relatively large biopsies of skin metastases
were in the range 4 x 105 to 8 x 106 nucleated cells.
Establishment ofcultures
For almost all samples, the total number of cells
obtained was split between 2 tissue culture flasks
(25cm2, Falcon Plastics) containing either HITES
defined medium or HITES supplemented with 2.5%
foetal calf serum (FCS). The HITES medium was
essentially identical to that described by Carney etSMALL CELL LUNG CANCER LINES 497
al. (1981) and consisted of RPMI 1640 (obtained as
10 x liquid from Gibco Biocult Ltd) supplemented
with hydrocortisone (10-8 M, Sigma), insulin
(50 gml-1, Sigma) transferrin (100 gml-1,
Sigma), oestradiol (10-8 M, Sigma) and sodium
selenite (3 xlO-8 M). We also added penicillin and
streptomycin (1OOuml-P and 100/igml-1
respectively, Gibco Biocult). All flasks were kept in
humidified gassing incubators maintained at 37°C
and gassed with 8% CO2 and 92% air.
Cell cultures were examined at weekly intervals.
Cultures showing no apparent cell growth were fed
every third week by centrifuging the cells (5 min at
200g) and replacing approximately two-thirds of
the medium. Cultures showing significant growth
were given a two-thirds medium change each week.
When no apparent growth had occurred after 6
months in culture, the flasks were discarded.
When cultures were growing sufficiently rapidly
that the pH of the medium was reduced between
weekly medium changes, the contents of the flask
were equally split between 2 small (25cm2) flasks.
When these became crowded, the contents were
transferred to 75 cm2 flasks. Cell lines were
considered to be established when the first split of
these 75 cm2 flasks became necessary. At this time a
frozen stock of cells was established in liquid
nitrogen for each line. This stage was typically
reached in 4-6 months from initiation of cultures.
The shortest time required was 6 weeks and the
longest 6 months.
Cultures which were initiated in HITES medium
without serum were kept in this medium until a line
was established or the flask discarded. Cultures
initiated in HITES plus 2.5% FCS were sometimes
observed to have an adherent layer of proliferating
fibroblasts. When these cells began to overgrow the
culture, the medium was switched to unsupple-
mented HITES. This generally resulted in a dying-
off of the fibroblasts and the culture was then
returned to HITES plus 2.5% FCS.
When cultures were established as cell lines in
75 cm2 flasks they were generally transferred to
RPMI 1640 medium with 10% FCS (but without
HITES additives) as a routine growth medium.
The two lines which grew as attached monolayers
(see Results) were subcultured using a 10min
exposure to trypsin (0.4%) and versene (0.02%).
Morphology and cytology
Morphological examination of growing cultures was
performed using an Olympus phase contrast
inverted microscope at 40 x, 100 x and 200 x
magnification. Cultures were examined for tightness
of aggregation, presence or absence of adherent
cells, and especially for the presence of uropods
on cells at the edge of aggregates (a known
characteristic of B-lymphoblastoid cells generated
by Epstein-Barr viral transformation (Nillson &
Klein, 1982)).
For cytological examination, cell aggregates from
growing cultures were broken up into smaller
aggregates by pipetting and then fixed in
Saccomonnos' fixative at 105cellsml-P. Aliquots of
0.5ml were then deposited onto microscope slides
using a 'cytospin' centrifuge (Shandon Ltd, UK).
These were then stained with haematoxylin and
eosin and mounted in 'Euparal'. Slides were kindly
examined by Dr Adi Gazdar of the NCI (Navy
Medical Oncology Branch, National Cancer
Institute, USA). Criteria such as nuclear/cyto-
plasmic ratio, presence of nucleoli, nuclear
chromatin distribution, nuclear indentation by
adjacent cells and the presence or absence of cyto-
plasmic uropods were used to classify the cells.
Small cell lung cancer cells were generally
considered to show only a thin rim of cytoplasm,
small, inconspicuous nucleoli, considerable indenta-
tion of nuclei by adjacent cells, a 'salt and pepper'
distribution of chromatin and no uropods. Cells
showing a higher ratio of cytoplasm to nucleus and
obvious uropods were considered to be B-lympho-
blastoid.
Electron microscopy
Aggregates of cells from growing cultures were
rinsed in PBS and fixed in 3% gluteraldelyde
buffered in Sorensen's phosphate buffer. These
cultures were then secondarily fixed in 1% buffered
osmium tetroxide for 5-10min and then con-
ventionally processed for electron microscopy and
embedded in Spurr's resin (Spurr, 1969). Sections
(70-100nm) were stained with uranyl acetate and
lead citrate and viewed in a JEM IOOCXII electron
microscope. The ultrastructural grading was under-
taken on at least ten spheroids or cell aggregations.
A further 15-20 spheroids were examined by light
microscopy of 1.Opm toluidine blue sections. The
ultrastructural grading was arbitrary, but carried
out by only one person (NFJ). Endocrine cell
differentiation was determined initially by the
presence of dense core vesicles and then by the
number and distribution of vesicles in relation to
cellular differentiation in terms of cell junctions,
intracellular fibrils, bound and free ribosomes and
the presence of smooth endoplasmic reticulum. The
grading was on a scale of 0-5. 0 represented a
culture of cells containing no dense core granules
irrespective of their degree of cytoplasmic
differentiation. Grades 1-3 represented poor to well
differentiated small cell carcinoma and grades 4 to 5
represent moderately and well differentiated
carcinoid tumours. (No cultures were assigned to
these latter 2 grades). The ultrastructural features498 H. BAILLIE-JOHNSON et al.
were based on recent descriptions by Kameya et al.
(1982) and Becker & Gazdar (1983).
Enzymatic assays
The method of Beaven et al. (1978) as modified by
Baylin et al. (1978) was used to assay L-dopa
decarboxylase (DDC). Cell aggregates containing an
estimated 2 x 106 to 2 x 107 cells were removed
from growing cultures and centrifuged at 200g for
5 min. The pellet was then washed once in PBS
followed by a wash in 0.1 M sodium phosphate
buffer, pH 6.8. The pellet was resuspended in 1.0ml
buffer and disrupted using an ultrasonic
disintegrator (MSE Mk2, 150 watt, amplitude set at
9 microns). The lysate was centrifuged at 1500g for
10 min and four aliquots of 0.2ml of supernatant
removed. Three aliquots were frozen at -20°C for
subsequent Lowry protein assay (Lowry et al., 1951)
or determination of creatine kinase BB (see below)
and the remainder used immediately for assay of
DDC. The reaction was started by mixing 25Ml
aliquots of the cell preparation and a reagent
solution. This reagent consisted of 0.1 M sodium
phosphate buffer pH 6.8 containing (i) L-3,4-
dihydroxyphenyl[l-4C] alanine (0.6mM;
3.2yCiml- 1; Amersham International); (ii)
unlabelled L-dopa (1.0 mM, Sigma) and (iii)
pyridoxal phosphate (20/iM, Sigma). The reaction
was allowed to proceed at 37°C for various time
periods, usually 5, 10 or 20 min, before stopping
with 25 jl of 0.2M perchloric acid. After a further
incubation at 37°C for 30min the assay mixture
was transferred to ice. Counting was carried out in
10ml of Aquasol-2 (New England Nuclear) using a
Nuclear Chicago Isocap 300 liquid scintillation
counter.
Although the reaction rate was never linear with
time beyond 10min there were large differences in
enzyme content between cell samples at any given
time. Because many of the DDC determinations
reported here were taken at 20min, on the non-
linear part of the curve, we cannot express the
results in terms of a reaction rate (nmolmg-I
protein h-'). Instead, the results are shown as
values calculated in relation to the DDC contents
of two controls which were used in all experiments.
Aliquots of 107 cells of NCI-H69 human SCLC and
107 cells of the EMT6/Ca/VJAC mouse tumour cell
line act as positive and negative controls
respectively. Calculation of the results is explained
in the footnotes to Table IV.
The activity of creatine kinase-BB(CK-BB) in
aliquots of frozen supernatants was determined by
radioimmune assay using a monoclonal antibody to
this enzyme (Jackson et al., 1984). These assays
were kindly carried out by Dr R.J. Thompson of
the Department of Clinical Biochemistry, University
of Cambridge.
Determination of the protein content of frozen
aliquots of supernatant were carried out using the
Lowry assay (Lowry et al., 1951).
Growth ofxenografts
Aggregates of cells from growing cultures were
mechanically dispersed, the cells washed and
resuspended in the Hanks' balanced salt solution so
that 0.05 ml contained between 106 and 5 x 106
viable cells. This volume was injected into the
gastocnemius muscle of the hind limb of groups of
4-6 MF1/Nu nude mice (OLAC 1976 Ltd). Mice
were examined weekly for evidence of tumour
growth and, when tumours grew progressively, the
tumour was excised and a sample fixed and
prepared for histology.
DNA index
Single cell suspensions were prepared from growing
cultures using trypsin (0.4%) plus versene (0.02%),
(15min), and diluted to 5 x 105 ml- I in RPMI 1640
medium with 10% FCS. A volume of 0.125 ml of
ethidium bromide/Triton X solution in water
(Taylor, 1980) was added to 1 ml of cell suspension
to release and stain nuclei. The cells were then run
through the Cambridge flow cytometer (Watson,
1980) using an argon laser operating at 488 nm.
DNA content per nucleus was measured on the
basis of the area under the pulse of fluorescence
output from each nucleus. Stained human
peripheral blood leucocytes or normal human
marrow cells were used to establish a DNA index
per nucleus of 1.0.
Results
Of the patients from whom samples for culture were
obtained, a total of 59 were already confirmed or
subsequently confirmed to have primary lung
cancer. Four of these were non-small cell and the
samples obtained were a pleural effusion from a
giant cell anaplastic carcinoma (COR-L23), a
marrow trephine from a poorly-differentiated
squamous cell carcinoma (COR-L32), a
pneumonectomy specimen from a large cell
anaplastic carcinoma (COR-L46) and a pleural
effusion from an adenocarcinoma (COR-L82). From
the 55 patients confirmed as SCLC, a total of 107
tissue samples were obtained and put into culture.
These consisted of 47 bone marrow aspirates, 42
bone marrow trephines, 6 lymph node biopsies, 4
biopsies of skin metastases, 5 pleural effusions and 3
bronchoscopy specimens.SMALL CELL LUNG CANCER LINES 499
NSCLC samples
Two out of the four NSCLC samples specified
above were established in culture. The pleural
effusion from a patient with giant cell anaplastic
carcinoma rapidly established as an adherent
monolayer. The bone marrow trephine from the
patient with poorly-differentiated squamous cell
carcinoma was established as floating aggregates
and the cell line characterised as SCLC (see data in
Table IV). A review of the pathology of the
patient's tumour, including primary and metastatic
sites has confirmed the original diagnosis.
SCLC - marrow samples
For the purposes of this section, a patient is
regarded as having a 'positive marrow' if either the
aspirate or trephine was reported as positive. The
aspirate and trephine specimens included are those
which were allowed 4-6 months in culture and
hence given a reasonable period of time for a cell
line to be established. Cultures becoming
contaminated at early times or lost in other ways
have been excluded. The results are shown in Table
I. It may be seen that, as expected, specimens from
patients with positive marrows produce a much
higher proportion of tumour cell lines (5/13) than
specimens from patients with negative marrows
(2/59).
Table I Establishment of culture of bone
marrow specimens from SCLC patients
Cell line establishedfrom
Marrow status
(pathology) Aspirate Trephine
+ 3/7 2/6
2/32k 3/27b
NK 3/4 1/3
Total 8/43 6/36
NK= Marrow status not known as specimen
unsuitable for pathology or lost in hospital
system; aincluding one B-lymphoblastoid line
(see Table III); bincluding two B-lymphoblast-
oid lines (see Table Ill).
SCLC- non-marrow samples
The samples other than bone marrows from SCLC
patients are shown in Table II. Of 3 bronchoscopy
specimens, one became contaminated in culture and
the other two failed to grow. From 10 secondary
deposit biopsy specimens, 3 lines were established, 5
specimens failed to grow and 2 became con-
taminated. From 5 pleural effusions, lines were
established from 3 and 2 failed to grow.
Table II Establishment in culture of non-marrow speci-
mens from SCLC patients
COR-L Tmour Culture
(Lab ref no.) source Pathology established
24 lymph node + +
30 lymph node +
33 bronchoscopy + NKa
34 bronchoscopy +
35 skin metastases + NKa
36 skin metastases +
41 pleural effusion + +
44 lymph node + NKa
47 lymph node + +
50 bronchoscopy +
51 pleural effusion ?b +
54 lymph node + +
76 pleural effusion NK -
77 pleural effusion NK -
80 skin metastases + -
85 skin metastases + -
88C pleural effusion + +
89 lymph node +
NK=Not known; acontaminated; blocally reported as
-ve, but a cytospin prepared from the separated cells put
into culture was said to 'contain one clump of malignant
cells' (Dr A. Gazdar, personal communication); cfrom a
patient in relapse after chemotherapy.
Comparison ofmedia
For each of the tissue specimens which produced a
cell line, we have compared the success in the two
different media used (HITES alone and HITES plus
2.5% FCS). The data are shown in Table III. When
the data for B-lymphoblastoid lines are excluded,
there remain 17 lines which were given an equal
opportunity in both media. Of these 17, nine were
successfully established in both media and eight
only in HITES plus 2.5% FCS. No specimen grew
successfully in HITES alone but not in HITES plus
2.5% FCS. However, it was sometimes necessary (as
stated in Materials and methods) for specimens
growing in HITES+2.5% FCS to be transferred to
HITES alone for some period of time to inhibit
fibroblast growth.
Characteristics ofestablished lines
The data for the various parameters measured on
established lines are shown in Table IV. The line
COR-L23 is very different from all the other lines in
terms of morphology and cytology. It grows as an
attached monolayer of very large cells, often multi-
nucleate. The DNA index is the highest we have
seen for any cell line. Both DDC and CK-BB values
are very low. The line produced tumours in 11/12
nude mice with a latent period of less than 4 weeks.
Sections of such tumours were described as poorly500 H. BAILLIE-JOHNSON et al.
Table Ill Establishment ofcell lines in different media
Line established
COR-L HITES HITES+
(Lab. ref: no) Type ofspecimen alone 2.5% FCS
23 pleural effusiona + NKb
24 lymph node + +
26 marrow aspirate _ +
27 marrow trephine - +
30 marrow aspirate - +
31 marrow aspirate + +
31 marrow trephine + +
32 marrow trephined + +
41 pleural effusion - +
42 marrow aspirate - +
42 marrow trephine NKe +
47 marrow aspirate - +
47 lymph node + +
51 pleural effusion + +
54 lymph node + +
59 lymph node - +f
64 marrow trephine + c
65 marrow trephine - +
71 marrow aspirate + +
80 marrow aspirate - +
80 marrow trephine - +
84 marrow aspirate NKs +
88 pleural effusion + +
NK=not known; alarge cell anaplastic carcinoma; bnot
given the opportunity to establish in this medium; cline is
B-lymphoblastoid; 'primary tumour pathology is poorly
differentiated squamous cell carcinoma; eculture lost due
to contamination; festablished line discarded before char-
acterisation due to being mycoplasma positive; 'poor cell
yield. Put into HITES +2.5% FCS only.
differentiated squamous cell by one consultant
pathologist and as adenocarcinoma by another. The
original patient from whom the line was derived
was diagnosed as 'giant cell anaplastic lung
carcinoma'. The line is, therefore, clearly non-small
cell and perhaps best described as large cell
anaplastic with some differentiated features.
The remaining 18 lines shown in Table IV all
appear to be either B-lymphoblastoid or small cell
lung cancer. Four of the lines COR-L26, COR-L30,
COR-L64 and COR-L65 show the presence of
uropods in growing cultures, appear to be non-
small cell on cytology, show no evidence under
electron microscopy of neuroendocrine
differentiation, are low for DDC and CK-BB and
did not form tumours in nude mice. They were all
derived from bone marrow specimens and grew
only in HITES+2.5% FCS and not in HITES
alone. The four lines also have surface immuno-
globulin. On the basis of these observations it
appears that these four lines are B-lymphoblastoid
(see Nillson & Klein, 1982).
Of the remaining 14 lines, one (COR-L59) was
found to be positive for mycoplasma and
characterisation was not proceeded with. The other
13 all have the cytological characteristics of SCLC.
Eleven of these were studied by electron microscopy
and nine were found to show some degree of
neuroendocrine differentiation. Two lines, however,
COR-L27 and COR-L54 had no neuroendocrine
features. The DNA content of the lines varied
considerably. Eight lines had close to the normal
diploid content (DNA index between 0.9 and 1.1)
whilst four lines had indices of 1.7 or greater. There
was no correlation between neuroendocrine
differentiation (by electron microscopy) and DNA
index. Ten of the lines were inoculated into small
numbers of nude mice and five lines produced at
least one tumour with latent periods ranging from
2-9 months. Sections of tumours from COR-L24,
COR-L31, COR-L47 and COR-L51 were kindly
examined by Dr Adi Gazdar and diagnosed as
consistent with small cell carcinoma. All the
tumours produced direct from cell culture were
successfully passaged into additional nude mice,
usually with a better take-rate and earlier onset of
growth.
Of the eleven putative SCLC lines tested for CK-
BB, all generally gave values in excess of
150ngmg-' protein in comparison with values of
<30ngmg'-I for the line COR-L23 and the four B-
lymphoblastoid lines. (It should be noted, however,
that one of the two values for COR-L47 (SCLC) is
lower than one of the values for COR-L30 (B-
lymphoblastoid).) There was much more spread in
the range of values for DDC. Three lines (COR-
L24, COR-L27 and COR-L80) consistently gave
very low values (<0.2) whereas six (COR-L32,
COR-L41, COR-L47, COR-L51, COR-L71 and
COR-L88) gave values similar to or in excess of
those for the standard SCLC line NCI-H69. One
line (COR-L41) was tested four times and gave three
very low values of <0.2 *and one considerably
higher value. The possible reasons for this are
currently being further investigated as are the
reasons for occasional discrepancies in repeat
determinations of CK-BB values.
Many of the cell lines have been continuously
passaged in culture for 12-24 months (50-100
passages) following initial characterisation. In none
of them has any gross change in culture
morphology (e.g. to adeno or squamous cell
carcinoma) been observed and the 'tightness of
aggregation' (see Table IV) has been very stable. No
repeat ultrastructural studies have been carried out
but determinations of L-dopa decarboxylase activity
carried out at later passages have been found to
give values similar to those originally obtained.SMALL CELL LUNG CANCER LINES 501
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Discussion
Establishment in culture of cell lines from patients
with small cell anaplastic carcinoma of the lung has
been previously reported (Gazdar et al., 1980;
Pettengill et al., 1980). Both of these groups used
tissue culture medium containing 20% foetal calf
serum. The lines obtained by the NCI group
(Gazdar et al., 1980) all grew as floating aggregates
of cells whereas those of the Dartmouth group
(Pettengill et al., 1980) grew both attached to plastic
or free floating or with a mixture of the two. In
both reports, all small cell lines were found to have
dense core vesicles (neurosecretory granules) when
examined by electron microscopy. Furthermore, in
the work of Gazdar et al. (1980) all lines were found
to have relatively high levels of the enzyme DDC,
considered to be a marker of APUD cells. More
recently, the NCI group have described the use of a
serum-free medium (HITES) (Carney et al., 1981)
for selective growth of SCLC cells. Some SCLC
lines have been found to possess 'variant'
morphology and to lack dense core granules and
the enzyme DDC. In addition, the doubling time of
such lines was reduced in comparison with 'classic'
SCLC and the cloning efficiency in soft agar was
higher (Carney et al., 1984). In addition to these
'morphological variants' a further category of
'biochemical variants' has been found in which the
cells show classic SCLC morphology but the
biochemical changes associated with 'morphological
variants'. Both variant types have high levels of
CK-BB. The appearance of growing aggregates of
cells has additionally been categorised into four
types (Carney et al., 1985; Gazdar et al., 1985).
In the present study we have characterised 19 cell
lines and believe that 14 of them are SCLC lines.
There is very considerable heterogeneity among the
lines. All four types of aggregation pattern are
represented although some lines show a mixture of
types. In general, levels of CK-BB were high in all
the SCLC lines but an occasional relatively low
value was seen. This observation is therefore in
accordance with the data of Gazdar et al. (1981) in
which high values of CK-BB were seen in SCLC
lines. The content of DDC was very variable
between lines. Of the three lines giving low values of
DDC, two were examined by electron microscopy.
One line (COR-L27) was found to show no
evidence of neuroendocrine differentiation whilst
another (COR-L80) showed only minimal
differentiation. All three lines however possessed
typical small cell cytological characteristics. They
would therefore appear to fall into the category of
'biochemical' variants, by the NCI classification.
We have not attempted in this study to use
population doubling time in culture or cloning
efficiency in soft agar as determinants of SCLC
culture type. It appears likely that the population
doubling time is a secondary characteristic of the
type of aggregates which different lines form, with
lines showing very tight aggregates a higher
proportion of non-cycling cells present. We are
currently investigating this point. Furthermore, we
believe that the low cloning efficiency claimed for
SCLC by Gazdar et al. (1980) results from the use
of non-optimal cloning conditions. We have found a
plating efficiency of -40% for line NCI-H69
compared with the value of 2.5% originally reported
by Gazdar et al. (1980), and several of the SCLC
lines described in the present paper have cloning
efficiencies in excess of 20% in the assay of
Courtenay & Mills (1978) (Twentyman & Walls,
1984; Walls & Twentyman, 1985).
It is interesting that line COR-L32 bearing
numerous SCLC characteristics evidently arose
from the marrow of a patient with poorly
differentiated squamous cell carcinoma. The
possibility of cross-contamination of cultures can
rarely be definitively ruled out but COR-L32 differs
in a number of ways from other SCLC lines
isolated at around the same time. Current thought
generally favours the concept that the various
histological types of lung carcinoma form a
differentiation continuum (Goodwin et al., 1983)
and it is not impossible therefore that a tumour
developing as a squamous primary may show
different characteristics following metastasis to the
marrow and growth in culture.
A major problem in initiating tumour cell lines
from biopsy material is that of fibroblast
overgrowth. We have found that splitting initial
samples between HITES and HITES+2.5% FCS
provides an excellent approach to this problem. Of
the lines reported here only COR-L23 was
established in HITES alone but not in HITES
+2.5% FCS (this line was not given the
opportunity to establish in HITES+2.5% FCS).
This is interesting in that HITES medium has been
described as specific for SCLC (Carney et al., 1981)
whereas COR-L23 is a non-small cell line. All other
lines established in HITES alone were also
established in HITES+2.5% FCS. We do however
have two more recent sets of lines (not reported in
this paper) where the lines established in HITES
alone appear on preliminary observation to be
SCLC whilst the lines established in HITES+2.5%
FCS appear to be B-lymphoblastoid. Such pairs of
lines have a number of potential roles in
experimental studies of antibodies directed against
SCLC-associated antigens. We would suggest,
however, that in cases where the number of cells
available was very limited, initial culture in HITES
+2.5% FCS with the option of switching to HITES
alone for a period of time if fibroblasts become
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Initially, all marrow samples were cultured and
observed for a period of 6 months despite negative
pathology reporting. This means a very large
investment of time and effort when the production
of lines from such samples is very rare. Unless one
is particularly interested in validating the
significance of negative marrow pathology it is
probably not a worthwhile effort. Growth of lines
from positive marrows, lymph node biopsies and
pleural effusions is, however, successful in sufficient
cases to justify the effort. It should of course be
realised that these are all metastatic sites and the
lines produced from such samples may not
necessarily be characteristic of the primary tumour
in the lung. Establishment of lines from
bronchoscopy specimens is fraught with difficulty.
The major difficulties are (a) the ethical justification
for re-bronchoscoping a patient in order to obtain a
sample for culture at some time after the original
diagnostic biopsy; (b) the very small size of the
specimen (which is frequently crushed) and (c) the
likelihood of bacterial or fungal contamination. We
have attempted to culture a number of
bronchoscopy specimens subsequent to those listed
in this paper and have only one still growing
although not yet established as a line. The NCI
group apparently have also had very limited success
in this direction (Dr D. Carney - personal
communication). The importance of establishing
lines from primary SCLC is however so great that
we believe that continued effort in this direction is
essential.
We are currently engaged in a wide range of
experimental studies using the lines described in this
paper. These include derivation and characterisation
of monoclonal antibodies to SCLC surface antigens
(Reeve et al., 1985), detailed examination ofchromo-
some abnormalities, studies of radiation and cyto-
toxic drug response, tumour cell heterogeneity and
mechanism of drug resistance.
We are indebted to Drs D. Carney and A. Gazdar of the
Navy/NCI Medical Oncology Branch for advice and
assistance on several occasions and to Dr Gazdar for
giving his opinion on a large number of cytology prepar-
ations. Dr P. Stovin, Department of Pathology,
Addenbrooke's Hospital, Cambridge, also kindly
examined a number of slides. We are also grateful to Dr
R. Thompson of the Department of Clinical Biochemistry,
University of Cambridge, for carrying out the CK-BB
analyses.
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